Center for Hematology-Oncology

Boca Raton, Florida 33486

0 studies enrolling now · 8 studies all time

What they study most

Adenocarcinoma of the Lung, Bladder Cancer, Breast Cancer, Breast Tumor, Cancer of the Breast, Colorectal Cancer, Estrogen Receptor- Negative Breast Cancer, HER2- Negative Breast Cancer, Metastatic Breast Cancer, Non-Small Cell Lung Cancer, Progesterone Receptor- Negative Breast Cancer, Prostate Cancer

Studies at this site

• A Safety and Efficacy Study of Farletuzumab in Participants With Adenocarcinoma of the Lung — Completed
• Evaluate Risk/Benefit of Nab Paclitaxel in Combination With Gemcitabine and Carboplatin Compared to Gemcitabine and Carboplatin in Triple Negative Metastatic Breast Cancer (or Metastatic Triple Negative Breast Cancer) — Completed
• A Study Comparing Bevacizumab Therapy With or Without Erlotinib for First-Line Treatment of Non-Small Cell Lung Cancer (ATLAS) — Completed
• Comparison of Three Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer — Status unconfirmed
• Irinotecan With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer — Completed
• Combination Chemotherapy Plus Filgrastim in Treating Patients With Locally Recurrent or Advanced Urothelium Cancer — Status unconfirmed
• Fluorouracil and Leucovorin With or Without Oxaliplatin in Treating Patients With Recurrent Metastatic Colorectal Cancer — Completed
• Expanded Access Study of Satraplatin Plus Prednisone in Patients With Hormone Refractory Prostate Cancer (HRPC) — Stopped early